Results 251 to 260 of about 6,916,201 (263)
Some of the next articles are maybe not open access.

Evaluation of Multispecific Drugs Based on Patient‐Derived Immunocompetent Tumor Organoids

ChemBioChem
AbstractThe evolution of antitumor drug development has transitioned from single‐agent chemotherapy to targeted therapy, immunotherapy, and more recently, multispecific drugs. These innovative drugs target multiple cellular or molecular pathways simultaneously, offering a more comprehensive anticancer approach and addressing some of the limitations ...
Zihan Zhao   +6 more
openaire   +2 more sources

Patient-derived organoids from normal and tumoral colorectal tissue

2019
Peer ...
Costales-Carrera, Alba   +5 more
openaire   +1 more source

Patient-Derived Organoids and Their Potential for Precision Medicine in Neuroendocrine Tumors

Endocrine Abstracts, 2023
Cortez Briana N   +11 more
openaire   +1 more source

INDIVIDUALIZED PATIENT-DERIVED TUMOR ORGANOIDS

2023
LIU HAIKUN   +9 more
openaire   +1 more source

Tumor organoids: Opportunities and challenges to guide precision medicine

Cancer Cell, 2021
Emile E Voest, Vivien Veninga
exaly  

Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients

International Journal of Molecular Sciences, 2023
Minyong Kang, So-Ra Jeong
exaly  

Home - About - Disclaimer - Privacy